GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (LSE:GENF) » Definitions » 12-1 Month Momentum %

Genflow Biosciences (LSE:GENF) 12-1 Month Momentum % : -64.67% (As of May. 02, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-02), Genflow Biosciences's 12-1 Month Momentum % is -64.67%.

The industry rank for Genflow Biosciences's 12-1 Month Momentum % or its related term are showing as below:

LSE:GENF's 12-1 Month Momentum % is ranked worse than
84.2% of 1481 companies
in the Biotechnology industry
Industry Median: -20.69 vs LSE:GENF: -64.67

Competitive Comparison of Genflow Biosciences's 12-1 Month Momentum %

For the Biotechnology subindustry, Genflow Biosciences's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genflow Biosciences's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genflow Biosciences's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Genflow Biosciences's 12-1 Month Momentum % falls into.



Genflow Biosciences  (LSE:GENF) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genflow Biosciences  (LSE:GENF) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Genflow Biosciences 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genflow Biosciences (LSE:GENF) Business Description

Traded in Other Exchanges
Address
6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences (LSE:GENF) Headlines

No Headlines